Guzman A. Topical Cantharidin Revisited: A Phase 2 Study Investigating a Commercially-Viable Formulation of Cantharidin (VP-102) for the Treatment of Molluscum Contagiosum. J of Skin [Internet]. 2018 Dec. 17 [cited 2024 Jul. 4];2:S103-S104. Available from: https://jofskin.org/33014/index.php/skin/article/view/447